Table of Content

1 Autoimmune Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of Autoimmune Monoclonal Antibodies
1.2 Autoimmune Monoclonal Antibodies Segment by Type
1.2.1 Global Autoimmune Monoclonal Antibodies Market Value Comparison by Type (2024-2034)
1.2.2 TNF Class
1.2.3 Interleukins
1.2.4 Integrins
1.2.5 B-Cell Depletion and Inhibition Targets
1.2.6 T Cell Depletion Targets
1.3 Autoimmune Monoclonal Antibodies Segment by Application
1.3.1 Global Autoimmune Monoclonal Antibodies Market Value by Application: (2024-2034)
1.3.2 Rheumatoid Arthritis
1.3.3 Systemic Lupus Erythematosus
1.3.4 Multiple Sclerosis
1.3.5 Organ Transplant Rejection
1.3.6 Others
1.4 Global Autoimmune Monoclonal Antibodies Market Size Estimates and Forecasts
1.4.1 Global Autoimmune Monoclonal Antibodies Revenue 2018-2029
1.4.2 Global Autoimmune Monoclonal Antibodies Sales 2018-2029
1.4.3 Global Autoimmune Monoclonal Antibodies Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Autoimmune Monoclonal Antibodies Market Competition by Manufacturers
2.1 Global Autoimmune Monoclonal Antibodies Sales Market Share by Manufacturers (2018-2024)
2.2 Global Autoimmune Monoclonal Antibodies Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Autoimmune Monoclonal Antibodies Average Price by Manufacturers (2018-2024)
2.4 Global Autoimmune Monoclonal Antibodies Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Autoimmune Monoclonal Antibodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Autoimmune Monoclonal Antibodies, Product Type & Application
2.7 Autoimmune Monoclonal Antibodies Market Competitive Situation and Trends
2.7.1 Autoimmune Monoclonal Antibodies Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Autoimmune Monoclonal Antibodies Players Market Share by Revenue
2.7.3 Global Autoimmune Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Autoimmune Monoclonal Antibodies Retrospective Market Scenario by Region
3.1 Global Autoimmune Monoclonal Antibodies Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Autoimmune Monoclonal Antibodies Global Autoimmune Monoclonal Antibodies Sales by Region: 2018-2029
3.2.1 Global Autoimmune Monoclonal Antibodies Sales by Region: 2018-2024
3.2.2 Global Autoimmune Monoclonal Antibodies Sales by Region: 2024-2029
3.3 Global Autoimmune Monoclonal Antibodies Global Autoimmune Monoclonal Antibodies Revenue by Region: 2018-2029
3.3.1 Global Autoimmune Monoclonal Antibodies Revenue by Region: 2018-2024
3.3.2 Global Autoimmune Monoclonal Antibodies Revenue by Region: 2024-2029
3.4 North America Autoimmune Monoclonal Antibodies Market Facts & Figures by Country
3.4.1 North America Autoimmune Monoclonal Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Autoimmune Monoclonal Antibodies Sales by Country (2018-2029)
3.4.3 North America Autoimmune Monoclonal Antibodies Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Autoimmune Monoclonal Antibodies Market Facts & Figures by Country
3.5.1 Europe Autoimmune Monoclonal Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Autoimmune Monoclonal Antibodies Sales by Country (2018-2029)
3.5.3 Europe Autoimmune Monoclonal Antibodies Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autoimmune Monoclonal Antibodies Market Facts & Figures by Country
3.6.1 Asia Pacific Autoimmune Monoclonal Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Autoimmune Monoclonal Antibodies Sales by Country (2018-2029)
3.6.3 Asia Pacific Autoimmune Monoclonal Antibodies Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Autoimmune Monoclonal Antibodies Market Facts & Figures by Country
3.7.1 Latin America Autoimmune Monoclonal Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Autoimmune Monoclonal Antibodies Sales by Country (2018-2029)
3.7.3 Latin America Autoimmune Monoclonal Antibodies Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Autoimmune Monoclonal Antibodies Market Facts & Figures by Country
3.8.1 Middle East and Africa Autoimmune Monoclonal Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Autoimmune Monoclonal Antibodies Sales by Country (2018-2029)
3.8.3 Middle East and Africa Autoimmune Monoclonal Antibodies Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Autoimmune Monoclonal Antibodies Sales by Type (2018-2029)
4.1.1 Global Autoimmune Monoclonal Antibodies Sales by Type (2018-2024)
4.1.2 Global Autoimmune Monoclonal Antibodies Sales by Type (2024-2029)
4.1.3 Global Autoimmune Monoclonal Antibodies Sales Market Share by Type (2018-2029)
4.2 Global Autoimmune Monoclonal Antibodies Revenue by Type (2018-2029)
4.2.1 Global Autoimmune Monoclonal Antibodies Revenue by Type (2018-2024)
4.2.2 Global Autoimmune Monoclonal Antibodies Revenue by Type (2024-2029)
4.2.3 Global Autoimmune Monoclonal Antibodies Revenue Market Share by Type (2018-2029)
4.3 Global Autoimmune Monoclonal Antibodies Price by Type (2018-2029)
5 Segment by Application
5.1 Global Autoimmune Monoclonal Antibodies Sales by Application (2018-2029)
5.1.1 Global Autoimmune Monoclonal Antibodies Sales by Application (2018-2024)
5.1.2 Global Autoimmune Monoclonal Antibodies Sales by Application (2024-2029)
5.1.3 Global Autoimmune Monoclonal Antibodies Sales Market Share by Application (2018-2029)
5.2 Global Autoimmune Monoclonal Antibodies Revenue by Application (2018-2029)
5.2.1 Global Autoimmune Monoclonal Antibodies Revenue by Application (2018-2024)
5.2.2 Global Autoimmune Monoclonal Antibodies Revenue by Application (2024-2029)
5.2.3 Global Autoimmune Monoclonal Antibodies Revenue Market Share by Application (2018-2029)
5.3 Global Autoimmune Monoclonal Antibodies Price by Application (2018-2029)
6 Key Companies Profiled
6.1 F. Hoffmann-La Roche Ltd
6.1.1 F. Hoffmann-La Roche Ltd Corporation Information
6.1.2 F. Hoffmann-La Roche Ltd Description and Business Overview
6.1.3 F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.1.4 F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Product Portfolio
6.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
6.2 Mylan N.V
6.2.1 Mylan N.V Corporation Information
6.2.2 Mylan N.V Description and Business Overview
6.2.3 Mylan N.V Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Mylan N.V Autoimmune Monoclonal Antibodies Product Portfolio
6.2.5 Mylan N.V Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Sanofi Autoimmune Monoclonal Antibodies Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Pfizer Inc
6.4.1 Pfizer Inc Corporation Information
6.4.2 Pfizer Inc Description and Business Overview
6.4.3 Pfizer Inc Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Pfizer Inc Autoimmune Monoclonal Antibodies Product Portfolio
6.4.5 Pfizer Inc Recent Developments/Updates
6.5 GSK plc
6.5.1 GSK plc Corporation Information
6.5.2 GSK plc Description and Business Overview
6.5.3 GSK plc Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.5.4 GSK plc Autoimmune Monoclonal Antibodies Product Portfolio
6.5.5 GSK plc Recent Developments/Updates
6.6 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Novartis AG Autoimmune Monoclonal Antibodies Product Portfolio
6.6.5 Novartis AG Recent Developments/Updates
6.7 Bayer AG
6.6.1 Bayer AG Corporation Information
6.6.2 Bayer AG Description and Business Overview
6.6.3 Bayer AG Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Bayer AG Autoimmune Monoclonal Antibodies Product Portfolio
6.7.5 Bayer AG Recent Developments/Updates
6.8 Lilly
6.8.1 Lilly Corporation Information
6.8.2 Lilly Description and Business Overview
6.8.3 Lilly Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Lilly Autoimmune Monoclonal Antibodies Product Portfolio
6.8.5 Lilly Recent Developments/Updates
6.9 Merck & Co., Inc
6.9.1 Merck & Co., Inc Corporation Information
6.9.2 Merck & Co., Inc Description and Business Overview
6.9.3 Merck & Co., Inc Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Merck & Co., Inc Autoimmune Monoclonal Antibodies Product Portfolio
6.9.5 Merck & Co., Inc Recent Developments/Updates
6.10 Sun Pharmaceutical Industries Ltd
6.10.1 Sun Pharmaceutical Industries Ltd Corporation Information
6.10.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
6.10.3 Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product Portfolio
6.10.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
6.11 Aurobindo Pharma
6.11.1 Aurobindo Pharma Corporation Information
6.11.2 Aurobindo Pharma Autoimmune Monoclonal Antibodies Description and Business Overview
6.11.3 Aurobindo Pharma Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Aurobindo Pharma Autoimmune Monoclonal Antibodies Product Portfolio
6.11.5 Aurobindo Pharma Recent Developments/Updates
6.12 Lupin
6.12.1 Lupin Corporation Information
6.12.2 Lupin Autoimmune Monoclonal Antibodies Description and Business Overview
6.12.3 Lupin Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Lupin Autoimmune Monoclonal Antibodies Product Portfolio
6.12.5 Lupin Recent Developments/Updates
6.13 Fresenius Kabi AG
6.13.1 Fresenius Kabi AG Corporation Information
6.13.2 Fresenius Kabi AG Autoimmune Monoclonal Antibodies Description and Business Overview
6.13.3 Fresenius Kabi AG Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Fresenius Kabi AG Autoimmune Monoclonal Antibodies Product Portfolio
6.13.5 Fresenius Kabi AG Recent Developments/Updates
6.14 Akorn Incorporated
6.14.1 Akorn Incorporated Corporation Information
6.14.2 Akorn Incorporated Autoimmune Monoclonal Antibodies Description and Business Overview
6.14.3 Akorn Incorporated Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Akorn Incorporated Autoimmune Monoclonal Antibodies Product Portfolio
6.14.5 Akorn Incorporated Recent Developments/Updates
6.15 Teva Pharmaceutical Industries Ltd
6.15.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.15.2 Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Description and Business Overview
6.15.3 Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product Portfolio
6.15.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autoimmune Monoclonal Antibodies Industry Chain Analysis
7.2 Autoimmune Monoclonal Antibodies Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autoimmune Monoclonal Antibodies Production Mode & Process
7.4 Autoimmune Monoclonal Antibodies Sales and Marketing
7.4.1 Autoimmune Monoclonal Antibodies Sales Channels
7.4.2 Autoimmune Monoclonal Antibodies Distributors
7.5 Autoimmune Monoclonal Antibodies Customers
8 Autoimmune Monoclonal Antibodies Market Dynamics
8.1 Autoimmune Monoclonal Antibodies Industry Trends
8.2 Autoimmune Monoclonal Antibodies Market Drivers
8.3 Autoimmune Monoclonal Antibodies Market Challenges
8.4 Autoimmune Monoclonal Antibodies Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Autoimmune Monoclonal Antibodies Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Autoimmune Monoclonal Antibodies Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Autoimmune Monoclonal Antibodies Market Competitive Situation by Manufacturers in 2022
Table 4. Global Autoimmune Monoclonal Antibodies Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Autoimmune Monoclonal Antibodies Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Autoimmune Monoclonal Antibodies Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Autoimmune Monoclonal Antibodies Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Autoimmune Monoclonal Antibodies Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Autoimmune Monoclonal Antibodies, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Autoimmune Monoclonal Antibodies, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Autoimmune Monoclonal Antibodies, Product Type & Application
Table 12. Global Key Manufacturers of Autoimmune Monoclonal Antibodies, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Autoimmune Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Monoclonal Antibodies as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Autoimmune Monoclonal Antibodies Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Autoimmune Monoclonal Antibodies Sales by Region (2018-2024) & (K Units)
Table 18. Global Autoimmune Monoclonal Antibodies Sales Market Share by Region (2018-2024)
Table 19. Global Autoimmune Monoclonal Antibodies Sales by Region (2024-2029) & (K Units)
Table 20. Global Autoimmune Monoclonal Antibodies Sales Market Share by Region (2024-2029)
Table 21. Global Autoimmune Monoclonal Antibodies Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Autoimmune Monoclonal Antibodies Revenue Market Share by Region (2018-2024)
Table 23. Global Autoimmune Monoclonal Antibodies Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Autoimmune Monoclonal Antibodies Revenue Market Share by Region (2024-2029)
Table 25. North America Autoimmune Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Autoimmune Monoclonal Antibodies Sales by Country (2018-2024) & (K Units)
Table 27. North America Autoimmune Monoclonal Antibodies Sales by Country (2024-2029) & (K Units)
Table 28. North America Autoimmune Monoclonal Antibodies Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Autoimmune Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Autoimmune Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Autoimmune Monoclonal Antibodies Sales by Country (2018-2024) & (K Units)
Table 32. Europe Autoimmune Monoclonal Antibodies Sales by Country (2024-2029) & (K Units)
Table 33. Europe Autoimmune Monoclonal Antibodies Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Autoimmune Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Autoimmune Monoclonal Antibodies Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Autoimmune Monoclonal Antibodies Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Autoimmune Monoclonal Antibodies Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Autoimmune Monoclonal Antibodies Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Autoimmune Monoclonal Antibodies Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Autoimmune Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Autoimmune Monoclonal Antibodies Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Autoimmune Monoclonal Antibodies Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Autoimmune Monoclonal Antibodies Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Autoimmune Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Autoimmune Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Autoimmune Monoclonal Antibodies Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Autoimmune Monoclonal Antibodies Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Autoimmune Monoclonal Antibodies Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Autoimmune Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Autoimmune Monoclonal Antibodies Sales (K Units) by Type (2018-2024)
Table 51. Global Autoimmune Monoclonal Antibodies Sales (K Units) by Type (2024-2029)
Table 52. Global Autoimmune Monoclonal Antibodies Sales Market Share by Type (2018-2024)
Table 53. Global Autoimmune Monoclonal Antibodies Sales Market Share by Type (2024-2029)
Table 54. Global Autoimmune Monoclonal Antibodies Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Autoimmune Monoclonal Antibodies Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Autoimmune Monoclonal Antibodies Revenue Market Share by Type (2018-2024)
Table 57. Global Autoimmune Monoclonal Antibodies Revenue Market Share by Type (2024-2029)
Table 58. Global Autoimmune Monoclonal Antibodies Price (US$/Unit) by Type (2018-2024)
Table 59. Global Autoimmune Monoclonal Antibodies Price (US$/Unit) by Type (2024-2029)
Table 60. Global Autoimmune Monoclonal Antibodies Sales (K Units) by Application (2018-2024)
Table 61. Global Autoimmune Monoclonal Antibodies Sales (K Units) by Application (2024-2029)
Table 62. Global Autoimmune Monoclonal Antibodies Sales Market Share by Application (2018-2024)
Table 63. Global Autoimmune Monoclonal Antibodies Sales Market Share by Application (2024-2029)
Table 64. Global Autoimmune Monoclonal Antibodies Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Autoimmune Monoclonal Antibodies Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Autoimmune Monoclonal Antibodies Revenue Market Share by Application (2018-2024)
Table 67. Global Autoimmune Monoclonal Antibodies Revenue Market Share by Application (2024-2029)
Table 68. Global Autoimmune Monoclonal Antibodies Price (US$/Unit) by Application (2018-2024)
Table 69. Global Autoimmune Monoclonal Antibodies Price (US$/Unit) by Application (2024-2029)
Table 70. F. Hoffmann-La Roche Ltd Corporation Information
Table 71. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 72. F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Product
Table 74. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 75. Mylan N.V Corporation Information
Table 76. Mylan N.V Description and Business Overview
Table 77. Mylan N.V Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Mylan N.V Autoimmune Monoclonal Antibodies Product
Table 79. Mylan N.V Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Sanofi Autoimmune Monoclonal Antibodies Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Pfizer Inc Corporation Information
Table 86. Pfizer Inc Description and Business Overview
Table 87. Pfizer Inc Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Pfizer Inc Autoimmune Monoclonal Antibodies Product
Table 89. Pfizer Inc Recent Developments/Updates
Table 90. GSK plc Corporation Information
Table 91. GSK plc Description and Business Overview
Table 92. GSK plc Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. GSK plc Autoimmune Monoclonal Antibodies Product
Table 94. GSK plc Recent Developments/Updates
Table 95. Novartis AG Corporation Information
Table 96. Novartis AG Description and Business Overview
Table 97. Novartis AG Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Novartis AG Autoimmune Monoclonal Antibodies Product
Table 99. Novartis AG Recent Developments/Updates
Table 100. Bayer AG Corporation Information
Table 101. Bayer AG Description and Business Overview
Table 102. Bayer AG Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Bayer AG Autoimmune Monoclonal Antibodies Product
Table 104. Bayer AG Recent Developments/Updates
Table 105. Lilly Corporation Information
Table 106. Lilly Description and Business Overview
Table 107. Lilly Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Lilly Autoimmune Monoclonal Antibodies Product
Table 109. Lilly Recent Developments/Updates
Table 110. Merck & Co., Inc Corporation Information
Table 111. Merck & Co., Inc Description and Business Overview
Table 112. Merck & Co., Inc Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Merck & Co., Inc Autoimmune Monoclonal Antibodies Product
Table 114. Merck & Co., Inc Recent Developments/Updates
Table 115. Sun Pharmaceutical Industries Ltd Corporation Information
Table 116. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 117. Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product
Table 119. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 120. Aurobindo Pharma Corporation Information
Table 121. Aurobindo Pharma Description and Business Overview
Table 122. Aurobindo Pharma Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Aurobindo Pharma Autoimmune Monoclonal Antibodies Product
Table 124. Aurobindo Pharma Recent Developments/Updates
Table 125. Lupin Corporation Information
Table 126. Lupin Description and Business Overview
Table 127. Lupin Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Lupin Autoimmune Monoclonal Antibodies Product
Table 129. Lupin Recent Developments/Updates
Table 130. Fresenius Kabi AG Corporation Information
Table 131. Fresenius Kabi AG Description and Business Overview
Table 132. Fresenius Kabi AG Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Fresenius Kabi AG Autoimmune Monoclonal Antibodies Product
Table 134. Fresenius Kabi AG Recent Developments/Updates
Table 135. Akorn Incorporated Corporation Information
Table 136. Akorn Incorporated Description and Business Overview
Table 137. Akorn Incorporated Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Akorn Incorporated Autoimmune Monoclonal Antibodies Product
Table 139. Akorn Incorporated Recent Developments/Updates
Table 140. Teva Pharmaceutical Industries Ltd Corporation Information
Table 141. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 142. Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product
Table 144. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Autoimmune Monoclonal Antibodies Distributors List
Table 148. Autoimmune Monoclonal Antibodies Customers List
Table 149. Autoimmune Monoclonal Antibodies Market Trends
Table 150. Autoimmune Monoclonal Antibodies Market Drivers
Table 151. Autoimmune Monoclonal Antibodies Market Challenges
Table 152. Autoimmune Monoclonal Antibodies Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Autoimmune Monoclonal Antibodies
Figure 2. Global Autoimmune Monoclonal Antibodies Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Autoimmune Monoclonal Antibodies Market Share by Type in 2022 & 2029
Figure 4. TNF Class Product Picture
Figure 5. Interleukins Product Picture
Figure 6. Integrins Product Picture
Figure 7. B-Cell Depletion and Inhibition Targets Product Picture
Figure 8. T Cell Depletion Targets Product Picture
Figure 9. Global Autoimmune Monoclonal Antibodies Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Autoimmune Monoclonal Antibodies Market Share by Application in 2022 & 2029
Figure 11. Rheumatoid Arthritis
Figure 12. Systemic Lupus Erythematosus
Figure 13. Multiple Sclerosis
Figure 14. Organ Transplant Rejection
Figure 15. Others
Figure 16. Global Autoimmune Monoclonal Antibodies Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Autoimmune Monoclonal Antibodies Market Size (2018-2029) & (US$ Million)
Figure 18. Global Autoimmune Monoclonal Antibodies Sales (2018-2029) & (K Units)
Figure 19. Global Autoimmune Monoclonal Antibodies Average Price (US$/Unit) & (2018-2029)
Figure 20. Autoimmune Monoclonal Antibodies Report Years Considered
Figure 21. Autoimmune Monoclonal Antibodies Sales Share by Manufacturers in 2022
Figure 22. Global Autoimmune Monoclonal Antibodies Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest Autoimmune Monoclonal Antibodies Players: Market Share by Revenue in 2022
Figure 24. Autoimmune Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 25. Global Autoimmune Monoclonal Antibodies Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 26. North America Autoimmune Monoclonal Antibodies Sales Market Share by Country (2018-2029)
Figure 27. North America Autoimmune Monoclonal Antibodies Revenue Market Share by Country (2018-2029)
Figure 28. United States Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Autoimmune Monoclonal Antibodies Sales Market Share by Country (2018-2029)
Figure 31. Europe Autoimmune Monoclonal Antibodies Revenue Market Share by Country (2018-2029)
Figure 32. Germany Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Autoimmune Monoclonal Antibodies Sales Market Share by Region (2018-2029)
Figure 38. Asia Pacific Autoimmune Monoclonal Antibodies Revenue Market Share by Region (2018-2029)
Figure 39. China Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. China Taiwan Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Autoimmune Monoclonal Antibodies Sales Market Share by Country (2018-2029)
Figure 47. Latin America Autoimmune Monoclonal Antibodies Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Autoimmune Monoclonal Antibodies Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Autoimmune Monoclonal Antibodies Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Autoimmune Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Autoimmune Monoclonal Antibodies by Type (2018-2029)
Figure 57. Global Revenue Market Share of Autoimmune Monoclonal Antibodies by Type (2018-2029)
Figure 58. Global Autoimmune Monoclonal Antibodies Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Autoimmune Monoclonal Antibodies by Application (2018-2029)
Figure 60. Global Revenue Market Share of Autoimmune Monoclonal Antibodies by Application (2018-2029)
Figure 61. Global Autoimmune Monoclonal Antibodies Price (US$/Unit) by Application (2018-2029)
Figure 62. Autoimmune Monoclonal Antibodies Value Chain
Figure 63. Autoimmune Monoclonal Antibodies Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed